0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-18I2851
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Global Type 1 Diabetes Treatment Market Size Status and Forecast 2021 2027

Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-18I2851
Report
July 2021
108 Pages
QYResearch
Region: Global, North America, Europe, Japan, Southeast Asia, Central & South America,
Description
Table of Content
Tables & Figures
Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes. 
Market Analysis and Insights: Global Type-1 Diabetes Treatment Market

The global Type-1 Diabetes Treatment market size is projected to reach US$ 7034.4 million by 2027, from US$ 5020 million in 2020, at a CAGR of 4.5% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type-1 Diabetes Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type-1 Diabetes Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type-1 Diabetes Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type-1 Diabetes Treatment market.
Global Type-1 Diabetes Treatment Scope and Market Size
Type-1 Diabetes Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Type-1 Diabetes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Rapid-Acting Insulin
Short-Acting Insulin
Others

Segment by Application

Hospitals & Clinics
Academic & Research Institutes

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rapid-Acting Insulin
1.2.3 Short-Acting Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Type-1 Diabetes Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Type-1 Diabetes Treatment Market Perspective (2016-2027)
2.2 Type-1 Diabetes Treatment Growth Trends by Regions
2.2.1 Type-1 Diabetes Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Type-1 Diabetes Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Type-1 Diabetes Treatment Industry Dynamic
2.3.1 Type-1 Diabetes Treatment Market Trends
2.3.2 Type-1 Diabetes Treatment Market Drivers
2.3.3 Type-1 Diabetes Treatment Market Challenges
2.3.4 Type-1 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type-1 Diabetes Treatment Players by Revenue
3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2016-2021)
3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio
3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2020
3.5 Type-1 Diabetes Treatment Key Players Head office and Area Served
3.6 Key Players Type-1 Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Type-1 Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type-1 Diabetes Treatment Breakdown Data by Type
4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2016-2021)
4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2022-2027)
5 Type-1 Diabetes Treatment Breakdown Data by Application
5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2016-2021)
5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Type-1 Diabetes Treatment Market Size (2016-2027)
6.2 North America Type-1 Diabetes Treatment Market Size by Type
6.2.1 North America Type-1 Diabetes Treatment Market Size by Type (2016-2021)
6.2.2 North America Type-1 Diabetes Treatment Market Size by Type (2022-2027)
6.2.3 North America Type-1 Diabetes Treatment Market Size by Type (2016-2027)
6.3 North America Type-1 Diabetes Treatment Market Size by Application
6.3.1 North America Type-1 Diabetes Treatment Market Size by Application (2016-2021)
6.3.2 North America Type-1 Diabetes Treatment Market Size by Application (2022-2027)
6.3.3 North America Type-1 Diabetes Treatment Market Size by Application (2016-2027)
6.4 North America Type-1 Diabetes Treatment Market Size by Country
6.4.1 North America Type-1 Diabetes Treatment Market Size by Country (2016-2021)
6.4.2 North America Type-1 Diabetes Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Type-1 Diabetes Treatment Market Size (2016-2027)
7.2 Europe Type-1 Diabetes Treatment Market Size by Type
7.2.1 Europe Type-1 Diabetes Treatment Market Size by Type (2016-2021)
7.2.2 Europe Type-1 Diabetes Treatment Market Size by Type (2022-2027)
7.2.3 Europe Type-1 Diabetes Treatment Market Size by Type (2016-2027)
7.3 Europe Type-1 Diabetes Treatment Market Size by Application
7.3.1 Europe Type-1 Diabetes Treatment Market Size by Application (2016-2021)
7.3.2 Europe Type-1 Diabetes Treatment Market Size by Application (2022-2027)
7.3.3 Europe Type-1 Diabetes Treatment Market Size by Application (2016-2027)
7.4 Europe Type-1 Diabetes Treatment Market Size by Country
7.4.1 Europe Type-1 Diabetes Treatment Market Size by Country (2016-2021)
7.4.2 Europe Type-1 Diabetes Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Type-1 Diabetes Treatment Market Size (2016-2027)
8.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type
8.2.1 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application
8.3.1 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region
8.4.1 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Type-1 Diabetes Treatment Market Size (2016-2027)
9.2 Latin America Type-1 Diabetes Treatment Market Size by Type
9.2.1 Latin America Type-1 Diabetes Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Type-1 Diabetes Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Type-1 Diabetes Treatment Market Size by Type (2016-2027)
9.3 Latin America Type-1 Diabetes Treatment Market Size by Application
9.3.1 Latin America Type-1 Diabetes Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Type-1 Diabetes Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Type-1 Diabetes Treatment Market Size by Application (2016-2027)
9.4 Latin America Type-1 Diabetes Treatment Market Size by Country
9.4.1 Latin America Type-1 Diabetes Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Type-1 Diabetes Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type-1 Diabetes Treatment Market Size (2016-2027)
10.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type
10.2.1 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application
10.3.1 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country
10.4.1 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.1.5 Astellas Pharma Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Type-1 Diabetes Treatment Introduction
11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Type-1 Diabetes Treatment Introduction
11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Company Details
11.7.2 Boehringer Ingelheim GmbH Business Overview
11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.7.5 Boehringer Ingelheim GmbH Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Type-1 Diabetes Treatment Introduction
11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.10.5 Abbott Laboratories Recent Development
11.11 Mannkind Corporation
11.11.1 Mannkind Corporation Company Details
11.11.2 Mannkind Corporation Business Overview
11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.11.5 Mannkind Corporation Recent Development
11.12 Braun Melsungen AG
11.12.1 Braun Melsungen AG Company Details
11.12.2 Braun Melsungen AG Business Overview
11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.12.5 Braun Melsungen AG Recent Development
11.13 Macrogenics, Inc.
11.13.1 Macrogenics, Inc. Company Details
11.13.2 Macrogenics, Inc. Business Overview
11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2016-2021)
11.13.5 Macrogenics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Rapid-Acting Insulin
    Table 3. Key Players of Short-Acting Insulin
    Table 4. Key Players of Others
    Table 5. Global Type-1 Diabetes Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Type-1 Diabetes Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Type-1 Diabetes Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Type-1 Diabetes Treatment Market Share by Regions (2016-2021)
    Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Type-1 Diabetes Treatment Market Share by Regions (2022-2027)
    Table 11. Type-1 Diabetes Treatment Market Trends
    Table 12. Type-1 Diabetes Treatment Market Drivers
    Table 13. Type-1 Diabetes Treatment Market Challenges
    Table 14. Type-1 Diabetes Treatment Market Restraints
    Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Type-1 Diabetes Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type-1 Diabetes Treatment as of 2020)
    Table 18. Ranking of Global Top Type-1 Diabetes Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Type-1 Diabetes Treatment Product Solution and Service
    Table 22. Date of Enter into Type-1 Diabetes Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Type-1 Diabetes Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Type-1 Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Type-1 Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Type-1 Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Type-1 Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Type-1 Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 37. North America Type-1 Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 38. Europe Type-1 Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Type-1 Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Type-1 Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Type-1 Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Type-1 Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 43. Europe Type-1 Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 44. Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 49. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 50. Latin America Type-1 Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Type-1 Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Type-1 Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Type-1 Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Type-1 Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 55. Latin America Type-1 Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 56. Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 61. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 62. Astellas Pharma Company Details
    Table 63. Astellas Pharma Business Overview
    Table 64. Astellas Pharma Type-1 Diabetes Treatment Product
    Table 65. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 66. Astellas Pharma Recent Development
    Table 67. Merck Company Details
    Table 68. Merck Business Overview
    Table 69. Merck Type-1 Diabetes Treatment Product
    Table 70. Merck Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 71. Merck Recent Development
    Table 72. Eli Lilly Company Details
    Table 73. Eli Lilly Business Overview
    Table 74. Eli Lilly Type-1 Diabetes Treatment Product
    Table 75. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 76. Eli Lilly Recent Development
    Table 77. Novo Nordisk Company Details
    Table 78. Novo Nordisk Business Overview
    Table 79. Novo Nordisk Type-1 Diabetes Treatment Product
    Table 80. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 81. Novo Nordisk Recent Development
    Table 82. Sanofi Company Details
    Table 83. Sanofi Business Overview
    Table 84. Sanofi Type-1 Diabetes Treatment Product
    Table 85. Sanofi Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 86. Sanofi Recent Development
    Table 87. AstraZeneca Company Details
    Table 88. AstraZeneca Business Overview
    Table 89. AstraZeneca Type-1 Diabetes Treatment Product
    Table 90. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 91. AstraZeneca Recent Development
    Table 92. Boehringer Ingelheim GmbH Company Details
    Table 93. Boehringer Ingelheim GmbH Business Overview
    Table 94. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
    Table 95. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 96. Boehringer Ingelheim GmbH Recent Development
    Table 97. Novartis Company Details
    Table 98. Novartis Business Overview
    Table 99. Novartis Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 100. Novartis Recent Development
    Table 101. Pfizer Inc. Company Details
    Table 102. Pfizer Inc. Business Overview
    Table 103. Pfizer Inc. Type-1 Diabetes Treatment Product
    Table 104. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 105. Pfizer Inc. Recent Development
    Table 106. Abbott Laboratories Company Details
    Table 107. Abbott Laboratories Business Overview
    Table 108. Abbott Laboratories Type-1 Diabetes Treatment Product
    Table 109. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 110. Abbott Laboratories Recent Development
    Table 111. Mannkind Corporation Company Details
    Table 112. Mannkind Corporation Business Overview
    Table 113. Mannkind Corporation Type-1 Diabetes Treatment Product
    Table 114. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 115. Mannkind Corporation Recent Development
    Table 116. Braun Melsungen AG Company Details
    Table 117. Braun Melsungen AG Business Overview
    Table 118. Braun Melsungen AG Type-1 Diabetes Treatment Product
    Table 119. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 120. Braun Melsungen AG Recent Development
    Table 121. Macrogenics, Inc. Company Details
    Table 122. Macrogenics, Inc. Business Overview
    Table 123. Macrogenics, Inc. Type-1 Diabetes Treatment Product
    Table 124. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2016-2021) & (US$ Million)
    Table 125. Macrogenics, Inc. Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type-1 Diabetes Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Rapid-Acting Insulin Features
    Figure 3. Short-Acting Insulin Features
    Figure 4. Others Features
    Figure 5. Global Type-1 Diabetes Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals & Clinics Case Studies
    Figure 7. Academic & Research Institutes Case Studies
    Figure 8. Type-1 Diabetes Treatment Report Years Considered
    Figure 9. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Type-1 Diabetes Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Type-1 Diabetes Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Type-1 Diabetes Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Type-1 Diabetes Treatment Market Share by Players in 2020
    Figure 14. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type-1 Diabetes Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2020
    Figure 16. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Type-1 Diabetes Treatment Market Share by Type (2016-2027)
    Figure 20. North America Type-1 Diabetes Treatment Market Share by Application (2016-2027)
    Figure 21. North America Type-1 Diabetes Treatment Market Share by Country (2016-2027)
    Figure 22. United States Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Type-1 Diabetes Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Type-1 Diabetes Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Type-1 Diabetes Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Type-1 Diabetes Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Type-1 Diabetes Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Type-1 Diabetes Treatment Market Share by Region (2016-2027)
    Figure 38. China Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Type-1 Diabetes Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Type-1 Diabetes Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Type-1 Diabetes Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Type-1 Diabetes Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Type-1 Diabetes Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Type-1 Diabetes Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Type-1 Diabetes Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 58. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 59. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 60. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 61. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 62. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 63. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 64. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 65. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 66. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 67. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 68. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 69. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global and United States Blood Glucose Device SMBG Market Insights Forecast to 2027
Global and United States Blood Glucose Device (SMBG) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34D6519
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China Disposable Insulin Pumps Market Insights Forecast to 2027
Global and China Disposable Insulin Pumps Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21D6700
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China Dipeptidyl Peptidase IV DPP IV Inhibitors Market Insights Forecast to 2027
Global and China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-8K6860
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global Insulin Cooler Box Sales Market Report 2021
Global Insulin Cooler Box Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-22F6167
Sat Aug 14 00:00:00 UTC 2021

Add to Cart